verified SJR 1,612 · Q1 • database Scopus / SJR & Web of Science indexed

Switzerland

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Molecular Diagnosis and Therapy

Molecular Diagnosis and Therapy is a journal indexed in SJR in Medicine (miscellaneous) and Genetics with an H index of 72. It has a price of 2990 €. It has an SJR impact factor of 1,612 and it has a best quartile of Q1. It has an SJR impact factor of 1,612.

ISSN: 1177-1062

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,612 Q1

H-index 72

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.990 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,612

H-index

Docs (year)

Docs 3y

168

Total refs

4738

Cites 3y

794

Citable 3y

167

Cites/Doc 2y

5.14

Ref/Doc

71.79

Immediate OA

2990 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarkers in the Clinical Diagnosis and Management of Traumatic Brain Injury

Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk

COBAS¬Æ AmpliPrep/COBAS¬Æ Taqman¬Æ HCV Quantitative Test, Version 2.0: An In Vitro Test for Hepatitis C Virus RNA Quantification

Clinical Utility of Next-Generation Sequencing in Acute Myeloid Leukemia

Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic

Circulating Tumor Cells as Markers for Cancer Risk Assessment and Treatment Monitoring

Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels

Celiac Disease

Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction

Calprotectin in Rheumatoid Arthritis

CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab

BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?

SHOW MORE ARTICLES

Blood-Based Biomarkers in Depression: Emerging Themes in Clinical Research

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention

Authors' Reply to Crampe and Langabeer: Technical Issues Behind Molecular Monitoring in Chronic Myeloid Leukemia

Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population

Are the Origins of Precision Medicine Found in the Corpus Hippocraticum?

Application of Various Statistical Models to Explore Gene-Gene Interactions in Folate, Xenobiotic, Toll-Like Receptor and STAT4 Pathways that Modulate Susceptibility to Systemic Lupus Erythematosus

Anticipating Clinical Resistance to Target-Directed Agents

Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression

An Integrated Approach to Defining Genetic and Environmental Determinants for Major Clinical Outcomes Involving Vitamin D

Advantages of Single-Stranded DNA Over Double-Stranded DNA Library Preparation for Capturing Cell-Free Tumor DNA in Plasma

A Simple Microfluidic Assay for the Detection of Ligation Product

A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband

FAQs

Molecular Diagnosis and Therapy has an SJR of 1,612 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2990 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Molecular Diagnosis and Therapy is 31%.

Molecular Diagnosis and Therapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Molecular Diagnosis and Therapy?

What is the APC / publication cost?

What is the acceptance rate?